Royalty Pharma plcRPRXNASDAQ
LOADING
|||
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
837.22%
↑ 328% above average
Average (26q)
195.55%
Historical baseline
Range
High:2033.96%
Low:-416.91%
Volatility
1253.3%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 837.22% |
| Q2 2025 | -86.99% |
| Q1 2025 | 17.07% |
| Q4 2024 | -61.53% |
| Q3 2024 | 437.27% |
| Q2 2024 | 2033.96% |
| Q1 2024 | -99.04% |
| Q4 2023 | 587.94% |
| Q3 2023 | -68.18% |
| Q2 2023 | -33.91% |
| Q1 2023 | 174.31% |
| Q4 2022 | -416.91% |
| Q3 2022 | -53.47% |
| Q2 2022 | 485.00% |
| Q1 2022 | 544.86% |
| Q4 2021 | -92.23% |
| Q3 2021 | -77.90% |
| Q2 2021 | 507.33% |
| Q1 2021 | -59.76% |
| Q4 2020 | -43.91% |
| Q3 2020 | -34.99% |
| Q2 2020 | 520.54% |
| Q1 2020 | -94.98% |
| Q4 2019 | 247.31% |
| Q3 2019 | 169.59% |
| Q2 2019 | -58.71% |
| Q1 2019 | 0.00% |